Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and fermentation method thereof

A receptor antagonist, interleukin technology, applied in the field of preparing recombinant interleukin-1 receptor antagonist, can solve the problems of high cost, low eukaryotic expression yield, good protein activity and the like, and achieves high bacterial yield , Good repeatability, fast growth of bacteria

Active Publication Date: 2011-04-06
BEIJING C & N INT SCI TECH
View PDF3 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Eukaryotic expression has low yield and high cost, but good protein activity

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and fermentation method thereof
  • Fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and fermentation method thereof
  • Fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and fermentation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Embodiment 1, construction IL-1ra engineered bacterium

[0051] Escherichia coli expression vector PET-30a was purchased from Novagen, catalog number: 69909-3;

[0052] Escherichia coli JM109 strain was purchased from Promega;

[0053] Escherichia coli strain BL21 (DE3) was purchased from MERCK;

[0054] The PHA-stimulated human peripheral blood T cell cDNA library was purchased from Clontech Laboratories.Inc, USA.

[0055] 1. Obtain IL-1ra gene

[0056] 1. PCR amplification of IL-1ra cDNA

[0057] Use the PHA-stimulated human peripheral blood T cell cDNA library as a template, add synthetic IL-1ra primers and dNTPs, and the upstream primer is: 5′-GG CATATG CGACCCTCTGGGA-3′, the downstream primer is: 5′-GGAGGACGAGTAA GTC GAC AA-3', the upstream primer introduces the NdeI restriction site, starting from the first amino acid encoding mature human IL-1ra, and the downstream primer introduces the efficient termination codon TAA and SalI restriction site of Escherichi...

Embodiment 2

[0102] Embodiment 2, fermentation process of recombinant interleukin-1 receptor antagonist

[0103] 1. Shake flask fermentation

[0104] 1. Seed cultivation

[0105] Inoculate the IL-1ra engineering bacteria monoclonal into a 250ml Erlenmeyer flask containing 50ml LB medium (the composition of LB medium is: tryptone 10g / L, yeast powder 5g / L and sodium chloride 10g / L), at 37°C, 200rpm, shaking culture for 12-15h, to obtain seeds.

[0106] 2. Fermentation bottle culture

[0107] On the basis of step 1, insert the seeds into 2×YT medium by 1% inoculum size (the composition of 2×YT medium is: tryptone 16g / L, yeast powder 10g / L and sodium chloride 5g / L) Fermentation flask, 37°C, 200rpm, shaking culture for 2-2.5h, OD 600 When it reaches 1.0 or so, add isopropyl-β-D thiogalactopyranoside (IPTG) to induce culture.

[0108] 3. Exploring the concentration of IPTG induction

[0109] Using shake flasks, in the fermentation broth OD 600 When it reaches 1.0, add IPTG respectively, t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a fermentation medium for preparing recombination IL-1ra (Interleukin-1 Receptor Antagonist) and a fermentation method thereof. The fermentation method comprises the following step of: inoculating recombination strains on the fermentation medium for fermentation cultivation to obtain a fermentation broth, namely obtaining a recombination IL-1ra. The recombination strains are recombination escherichia coli obtained by guiding genes shown in sequence 1 in a sequence table into escherichia coli, and the guided genes which are shown in the sequence 1 in the sequence table are guided into the escherichia coli via the following recombination expression vectors: inserting the genes shown in the sequence 1 of the sequences into multiple clone sites of a PET-30a vector to obtain the recombination expression vectors. The method has good repeatability; the growth of the strains is fast so as to greatly shorten the period of fermentation; the yield of the strain is high, which can meet the high-density fermentation requirements, and target proteins has high expression rate and good solubility.

Description

technical field [0001] The invention relates to a fermentation medium for preparing recombinant interleukin-1 receptor antagonist and a fermentation method thereof. Background technique [0002] Recombinant interleukin-1 receptor antagonist (IL-1ra for short) is a protein cytokine receptor antagonist that exists in the human body. By binding to interleukin-1 (IL-1) receptor, it specifically Blocks the activity of IL-1. [0003] Since Arend and others cloned the cDNA of human IL-1ra in 1990, scholars from various countries have been conducting more comprehensive and in-depth research on IL-1ra. At the same time, many pharmaceutical manufacturers are also working on the development of IL-1ra. In 2003, the US FDA approved the recombinant human IL-1ra (trade name Kineret) produced by Amgen Company for the treatment of rheumatoid arthritis. my country's SFDA approved recombinant human IL-1ra produced by Tibet Huaxi Pharmaceutical Co., Ltd. in 2008 for the treatment of ocular no...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12P21/00C12R1/19
Inventor 揣文华梁伟锋韩普王瑞琳洪海燕
Owner BEIJING C & N INT SCI TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products